Tag Archives: clinical trials

Studies Show Many Providers Think There is a Screening Test for Ovarian Cancer

Two studies released this week indicate that health care providers believe that the CA-125 and/or the transvaginal ultrasound are appropriate screening tests for ovarian cancer. There is no medical organization … Continue reading 

Posted in News | Also tagged , , , , , , , , , | Leave a comment

Study Argues for Increased Use of PARP Inhibitors

A study from the Oregon Health & Science University suggests that women who have a recurrence of ovarian cancer would benefit from PARP inhibitors, now being tested in women with hereditary … Continue reading 

Posted in News | Also tagged , , , | Leave a comment

Avastin Shown to Slow Tumor Growth; Not Prolong Life

Two studies of the use of Avastin in ovarian cancer showed that the drug slowed tumor growth but did not improve overall survival. “While we are looking for that silver … Continue reading 

Posted in News | Also tagged , , , , , , | Leave a comment

PARP Inhibitor Olarparib Fails to Meet Trial Endpoints

AstraZeneca announced that it would not continue trials of olarparib in ovarian cancer due to the results of the Phase II trial. The company’s press release is available here

Posted in News | Also tagged , , , | Leave a comment

EU Approves Use of Avastin for Ovarian Cancer

The European Commission has approved the use of Avastin in women newly diagnosed with ovarian cancer. Read more on this topic here

Posted in News | Also tagged , , , | Leave a comment

Screening Study for Ovarian Cancer

A new study of 545 women with a family history of ovarian cancer were  provided annual screening with the CA-125 blood test and transvaginal ultrasound. This interval of testing with … Continue reading 

Posted in News | Also tagged , , , | Leave a comment

Women with BRCA2 Mutation in Ovarian Tumors have Higher Surivival Rates

A recent study shows that women with ovarian cancer who have the BRCA2 mutation live longer than those with the BRCA1 mutation. Because the BRCA1 and BRCA2 mutations works slightly … Continue reading 

Posted in News | Also tagged , , , , , , | Leave a comment

Ovarian Cancer a Mystery, Especially for Black Women

The Grio reports that African American women are not well represented in clincial trials related to ovarian cancer. The article discusses a new trial meant to explore the epidemiology of … Continue reading 

Posted in News | Also tagged , , , , , | Leave a comment

Fluorescent Light Helps Doctors Identify Ovarian Cells

Doctors have used a special dye to track tumors during surgery. The dye makes ovarian cancer cells glow under fluorescent light. The study had 10 ovarian cancer patients, and may allow … Continue reading 

Posted in News | Also tagged , | Leave a comment

Another Ovarian Cancer Vaccine Trial Approved

MXi Pharmaceuticals has recieved approval to begin a trial for ovarian/uterine cancer. The company hopes to start enrolling patients this calendar year. See the news release here Enroll in clinical … Continue reading 

Posted in News | Also tagged , , | Leave a comment

The Annals of Extreme Surgery (NYT)

The New York Times ran an op-ed about the lack of evidence supporting heated chemotherapy (HIPEC). The article stated that while this new treatment gives patients hope, the data is … Continue reading 

Posted in News | Also tagged , , , | Leave a comment

Less than One Percent of Cancer Patients Enroll in Trials

A study based on the California Cancer Registry found that less than one percent of cancer patients enroll in clinical trials. Black patients, those older than 65, those with early … Continue reading 

Posted in News | Leave a comment